Q4 2023 · 13F-HR
Atle Fund Management ABholdings as filed
Filed 2024-01-30 · accession 0001381843-24-000002
$127.8M
Reported value
45
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $9.7M | 7.59% | 18,408 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $9.2M | 7.21% | 15,805 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $8.0M | 6.28% | 98,974 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $8.0M | 6.26% | 38,925 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $7.2M | 5.60% | 65,675 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $6.1M | 4.74% | 11,415 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $4.8M | 3.79% | 48,000 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $4.7M | 3.67% | 145,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $4.6M | 3.61% | 16,023 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $4.6M | 3.60% | 62,000 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $4.5M | 3.54% | 12,500 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $4.5M | 3.53% | 88,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $4.5M | 3.52% | 15,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $4.5M | 3.51% | 9,500 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $3.8M | 3.00% | 12,802 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $3.7M | 2.93% | 64,806 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $3.7M | 2.91% | 9,130 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $3.5M | 2.74% | 3,979 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $3.3M | 2.57% | 21,196 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $2.4M | 1.87% | 10,340 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $2.2M | 1.75% | 18,057 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.7M | 1.30% | 12,617 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $1.6M | 1.24% | 20,815 | Common | SOLE |
| 68404L201 | OPCH | OPTION CARE HEALTH INC | $1.3M | 0.98% | 37,223 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $1.2M | 0.96% | 42,820 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $1.2M | 0.96% | 24,243 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $1.2M | 0.94% | 125,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $979,588 | 0.77% | 11,733 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $968,274 | 0.76% | 23,985 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $899,375 | 0.70% | 12,157 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $876,987 | 0.69% | 12,245 | Common | SOLE |
| 641871108 | — | AMBRX BIOPHARMA INC | $823,741 | 0.64% | 57,847 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $821,773 | 0.64% | 6,624 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $691,195 | 0.54% | 48,710 | Common | SOLE |
| 82489T104 | SWAVUSD | SHOCKWAVE MED INC | $672,677 | 0.53% | 3,530 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $668,938 | 0.52% | 24,325 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $656,875 | 0.51% | 3,229 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $632,700 | 0.50% | 11,400 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $620,462 | 0.49% | 96,345 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $585,623 | 0.46% | 2,531 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $534,467 | 0.42% | 7,823 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $476,700 | 0.37% | 21,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $431,814 | 0.34% | 14,952 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $360,337 | 0.28% | 15,432 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $303,148 | 0.24% | 8,342 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.